Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval to India-based pharma firm Bafna Pharmaceuticals to manufacture Amlodipine 5mg and Amlodipine 10mg.
Subscribe to our email newsletter
Amlodipine is said to be a calcium channel blocker (dihydropyridine class) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle and is used as an anti-hypertensive and in the treatment of angina.
Bafna Pharma chairman and MD Mahaveer Chand as quoted by Pharmabiz saying that the approval from UK MHRA for Amlodipine 5mg and Amlodipine 10mg will provide further drive to the current expansion efforts in the European region.
"UK MHRA approval will enable Bafna Pharma to widen the customer base in Europe," Chand said.